Advertisement

Topics

First Fibroblast Injection Performed in SpinalCyte’s Landmark Trial for Spinal Disc Regeneration

10:22 EDT 14 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on the regrowth of the spinal disc nucleus using human dermal fibroblasts, announced the first injection of fibroblasts for the regeneration of ...

Other Sources for this Article

Investor Contact:
SpinalCyte, LLC
Pete O’Heeron, 281.461.6211
CEO
info@spinalcyte.com
or
Media Contact:
Pierpont Communications
Brittney Garneau, 713.627.2223
bgarneau@piercom.com

NEXT ARTICLE

More From BioPortfolio on "First Fibroblast Injection Performed in SpinalCyte’s Landmark Trial for Spinal Disc Regeneration"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Anesthesia
Anesthesia is the loss of feeling or sensation in all or part of the body. It may result from damage to nerves or can be induced by an anesthetist (a medical professional) using anesthetics such as thiopental or propofol or sevoflurane during a surgical ...

Gene Expression
The process of gene expression is used by eukaryotes, prokaryotes, and viruses to generate the macromolecular machinery for life. Steps in the gene expression process may be modulated, including the transcription, RNA splicing, translation, and post-tran...